DDIT3 and angioimmunoblastic T-cell lymphoma: Importantly, our results showed that CHOP could induce a favorable outcome in patients with AITL, although the efficacy of CHOP was unsatisfactory in patients with PTCL-NOS and EATL/HSTL.